$52.85B
Revenue
$-267.00M
Net Income
34.77%
Gross Margin
-4.19%
Op. Margin
$-15.19B
Free Cash Flow
| Breakdown | TTM (Dec 27, 2025) |
FY 2025 (Dec 27, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | $52.85B | $52.85B | $53.10B | $54.23B | $63.05B | $79.02B |
| Revenue Growth % | 0.0% | -0.5% | -2.1% | -14.0% | -20.2% | nan% |
| Cost of Revenue | $34.48B | $34.48B | $35.76B | $32.52B | $36.19B | $35.21B |
| Gross Profit | $18.38B | $18.38B | $17.34B | $21.71B | $26.87B | $43.81B |
| Gross Margin % | 34.8% | 34.8% | 32.7% | 40.0% | 42.6% | 55.4% |
| Operating Expenses | $20.59B | $20.59B | $29.02B | $21.62B | $24.53B | $24.36B |
| Research & Development | $13.77B | $13.77B | $16.55B | $16.05B | $17.53B | $15.19B |
| Selling General & Admin | $4.62B | $4.62B | $5.51B | $5.63B | $7.00B | $6.54B |
| Operating Income | $-2.21B | $-2.21B | $-11.68B | $93.00M | $2.33B | $19.46B |
| Operating Margin % | -4.2% | -4.2% | -22.0% | 0.2% | 3.7% | 24.6% |
| Interest Expense | $2.25B | $1.11B | $987.00M | $613.00M | $459.00M | $545.00M |
| Interest Income | - | $1.01B | - | - | - | - |
| Other Income/Expense | $-416.00M | $-416.00M | $226.00M | $629.00M | $1.17B | $-482.00M |
| Income Before Tax | $1.56B | $1.56B | $-11.21B | $762.00M | $7.77B | $21.70B |
| Income Tax Expense | $1.53B | $1.53B | $8.02B | $-913.00M | $-249.00M | $1.83B |
| Net Income | $-267.00M | $-267.00M | $-18.76B | $1.69B | $8.01B | $19.87B |
| Net Margin % | -0.5% | -0.5% | -35.3% | 3.1% | 12.7% | 25.1% |
| Basic EPS | -0.09 | -0.06 | -4.38 | 0.40 | 1.95 | 4.89 |
| Diluted EPS | -0.09 | -0.06 | -4.38 | 0.40 | 1.94 | 4.86 |
| Basic Shares Outstanding | - | 4.53B | 4.28B | 4.19B | 4.11B | 4.06B |
| Diluted Shares Outstanding | - | 4.53B | 4.28B | 4.21B | 4.12B | 4.09B |
| Breakdown | FY 2025 (Dec 27, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $14.27B | - | - | - | - |
| Accounts Receivable | $3.84B | $3.48B | $3.40B | $4.13B | $9.46B |
| Inventory | $11.62B | $12.20B | $11.13B | $13.22B | $10.78B |
| Other Current Assets | $10.81B | $9.59B | $3.71B | $4.67B | $2.13B |
| Total Current Assets | $63.69B | $47.32B | $43.27B | $50.41B | $57.72B |
| Property Plant & Equipment | - | - | - | $80.86B | $63.24B |
| Goodwill | $23.91B | $24.69B | $27.59B | $27.59B | $26.96B |
| Intangible Assets | $2.77B | $3.69B | $4.59B | $6.02B | $7.27B |
| Other Non-current Assets | $7.13B | $7.47B | $13.65B | $11.31B | $6.07B |
| Total Assets | $211.43B | $196.49B | $191.57B | $182.10B | $168.41B |
| Accounts Payable | $9.88B | $12.56B | $8.58B | $9.60B | $5.75B |
| Short-term Debt | $2.50B | $3.73B | $2.29B | $4.37B | $4.59B |
| Other Current Liabilities | $14.60B | $14.28B | $12.43B | $11.86B | $12.59B |
| Total Current Liabilities | $31.57B | $35.67B | $28.05B | $32.16B | $27.46B |
| Long-term Debt | $46.59B | $46.28B | $46.98B | $37.68B | $33.51B |
| Deferred Tax Liabilities | $1.69B | - | - | $202.00M | $2.67B |
| Other Non-current Liabilities | $9.41B | $9.51B | $6.58B | $4.98B | $4.89B |
| Common Stock | $65.19B | $50.95B | $36.65B | $31.58B | $28.01B |
| Retained Earnings | $48.98B | $49.03B | $69.16B | $70.41B | $68.27B |
| Total Stockholders Equity | $114.28B | $99.27B | $105.59B | $101.42B | $95.39B |
| Total Liabilities & Equity | $211.43B | $196.49B | $191.57B | $182.10B | $168.41B |
| Breakdown | TTM (Dec 27, 2025) |
FY 2025 (Dec 27, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $-1.09B | $-267.00M | $-18.76B | $1.69B | $8.01B | $19.87B |
| Stock-based Compensation | $4.47B | $2.43B | $3.41B | $3.23B | $3.13B | $2.04B |
| Deferred Income Tax | $454.00M | $329.00M | - | - | - | - |
| Change in Receivables | $-969.00M | $449.00M | $75.00M | $-731.00M | $-5.33B | $2.67B |
| Change in Inventory | $122.00M | $138.00M | $1.10B | $-2.10B | $2.44B | $2.34B |
| Change in Payables | $171.00M | $297.00M | $634.00M | $-801.00M | $-29.00M | $1.19B |
| Operating Cash Flow | $13.37B | $9.70B | $8.29B | $11.47B | $15.43B | $29.99B |
| Capital Expenditure | $28.56B | $14.65B | $23.94B | $25.75B | $24.84B | $18.73B |
| Acquisitions | - | - | $82.00M | $13.00M | $681.00M | $209.00M |
| Sales of Investments | - | - | - | - | - | $6.47B |
| Investing Cash Flow | $-16.75B | $-14.82B | $-18.26B | $-24.04B | $-10.48B | $-25.17B |
| Debt Repayment | $6.75B | $3.75B | $2.29B | $423.00M | $4.98B | $2.50B |
| Stock Repurchased | - | - | - | - | - | $2.42B |
| Dividends Paid | - | - | $1.60B | $3.09B | $6.00B | $5.64B |
| Financing Cash Flow | $11.98B | $11.59B | $11.14B | $8.51B | $1.36B | $-5.86B |
| Net Change in Cash | $8.61B | $6.46B | $1.17B | $-4.07B | $6.32B | $-1.04B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $13.65B | $13.28B | $39.18B | $38.84B |
| Cost of Revenue | $8.44B | $11.29B | $25.75B | $27.08B |
| Gross Profit | $5.22B | $2.00B | $13.43B | $11.76B |
| Operating Expenses | $4.54B | $11.05B | $16.23B | $23.85B |
| Research & Development | $3.23B | $4.05B | $10.55B | $12.67B |
| Selling General & Admin | $1.13B | $1.38B | $3.45B | $4.27B |
| Operating Income | $683.00M | $-9.06B | $-2.79B | $-12.09B |
| Interest Expense | - | - | $1.16B | $1.10B |
| Other Income/Expense | $3.67B | $130.00M | $3.40B | $355.00M |
| Income Before Tax | $4.57B | $-9.09B | $1.22B | $-11.81B |
| Income Tax Expense | $304.00M | $7.90B | $860.00M | $7.27B |
| Net Income | $4.06B | $-16.64B | $324.00M | $-18.63B |
| Basic EPS | 0.90 | -3.88 | 0.07 | -4.37 |
| Diluted EPS | 0.90 | -3.88 | 0.07 | -4.37 |
| Basic Shares Outstanding | $4.51B | $4.29B | $4.42B | $4.27B |
| Diluted Shares Outstanding | $4.53B | $4.29B | $4.43B | $4.27B |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $11.14B | $8.25B |
| Accounts Receivable | $3.20B | $3.48B |
| Inventory | $11.49B | $12.20B |
| Other Current Assets | $6.11B | $9.59B |
| Total Current Assets | $51.73B | $47.32B |
| Goodwill | $23.91B | $24.69B |
| Intangible Assets | $2.88B | $3.69B |
| Other Non-current Assets | $12.28B | $7.47B |
| Total Assets | $204.51B | $196.49B |
| Accounts Payable | $10.27B | $12.56B |
| Short-term Debt | $2.50B | $3.73B |
| Other Current Liabilities | $14.95B | $14.28B |
| Total Current Liabilities | $32.30B | $35.67B |
| Long-term Debt | $44.06B | $46.28B |
| Other Non-current Liabilities | $11.43B | $9.51B |
| Common Stock | $56.76B | $50.95B |
| Retained Earnings | $49.60B | $49.03B |
| Total Stockholders Equity | $106.38B | $99.27B |
| Total Liabilities & Equity | $204.51B | $196.49B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $4.06B | $-16.64B | $324.00M | $-18.63B |
| Stock-based Compensation | - | - | $1.90B | $2.76B |
| Deferred Income Tax | - | - | $123.00M | $6.37B |
| Change in Receivables | - | - | $-162.00M | $-282.00M |
| Change in Inventory | - | - | $9.00M | $969.00M |
| Change in Payables | - | - | $-281.00M | $566.00M |
| Operating Cash Flow | - | - | $5.41B | $5.12B |
| Capital Expenditure | - | - | $11.16B | $18.11B |
| Sales of Investments | - | - | $10.96B | $34.27B |
| Investing Cash Flow | - | - | $-8.26B | $-14.49B |
| Debt Repayment | - | - | $3.75B | $2.29B |
| Dividends Paid | - | - | - | $1.60B |
| Financing Cash Flow | - | - | $5.74B | $11.07B |
| Net Change in Cash | - | - | $2.89B | $1.71B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.